Skip to main content

Jatin Shah

Equibles does not estimate personal net worth.

About Jatin Shah

The proxy statement of Karyopharm Therapeutics Inc. reports total compensation of $1,588,213 for Jatin Shah in fiscal 2021, including a base salary of $457,980.

Affiliation history

Company network

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2021 Karyopharm Therapeutics Inc. (KPTI) $457,980 $1,588,213

Recent activity

No call appearances or filed executive changes recorded yet.